Impact of Residual Renal Function on Plasma Levels of Advanced Oxidation Protein Products and Pentosidine in Peritoneal Dialysis Patients

被引:34
作者
Furuya, Ryuichi [1 ]
Kumagai, Hiromichi [2 ]
Odamaki, Mari [2 ]
Takahashi, Masaaki [3 ]
Miyaki, Asumi [1 ]
Hishida, Akira [4 ]
机构
[1] Iwata City Hosp, Div Renal, Dept Internal Med, Iwata 4388550, Japan
[2] Univ Shizuoka, Sch Food & Nutr Sci, Dept Clin Nutr, Shizuoka 4228526, Japan
[3] Hamamatsu Univ Sch Med, Dept Orthoped Surg, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka, Japan
来源
NEPHRON CLINICAL PRACTICE | 2009年 / 112卷 / 04期
关键词
Residual renal function; Advanced oxidation protein products; Pentosidine; Peritoneal dialysis; GLYCATION END-PRODUCTS; HEMODIALYSIS-PATIENTS; MONOCYTE ACTIVATION; MORTALITY; INFLAMMATION; ADEQUACY; THERAPY; FAILURE; STRESS; RISK;
D O I
10.1159/000224792
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
Background: Residual renal function (RRF) affects the survival rate and the development of cardiovascular disease in peritoneal dialysis (PD) patients. We evaluated the impact of RRF on oxidative and carbonyl stress in PD patients. Methods: Plasma advanced oxidation protein products (AOPP) and pentosidine were measured in PD patients with a urine volume of >= 300 ml/day (group A, n = 17) and <300 ml/day (group B, n = 14). AOPP and pentosidine were reevaluated after 12 months of follow-up in group A. Results: Plasma levels of AOPP and pentosidine in group A were significantly lower than those in group B. Renal creatinine clearance was inversely correlated with AOPP (p < 0.05) and pentosidine (p < 0.01). After 12 months of follow-up, no significant change was observed in AOPP and pentosidine in groups who maintained a urine volume of >= 300 ml/day, but significantly increased in groups whose urine volume decreased to less than 300 ml/day. There were significant inverse relationships between the changes in renal creatinine clearance and AOPP (p < 0.01) and pentosidine (p < 0.05). Conclusion: Loss of RRF is associated with increased plasma AOPP and pentosidine, indicating that preservation of RRF has a beneficial effect in reducing the oxidative and carbonyl stress in PD patients. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:C255 / C261
页数:7
相关论文
共 31 条
[1]
Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients [J].
Bammens, B ;
Evenepoel, P ;
Verbeke, K ;
Vanrenterghem, Y .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (03) :512-519
[2]
Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158
[3]
Chapman GV., 1981, Peritoneal dialysis, P180
[4]
Serum β-2 microglobulin levels predict mortality in dialysis patients:: Results of the HEMO study [J].
Cheung, Alfred K. ;
Rocco, Michael V. ;
Yan, Guofen ;
Leypoldt, John K. ;
Levin, Nathan W. ;
Greene, Tom ;
Agodoa, Lawrence ;
Bailey, James ;
Beck, Gerald J. ;
Clark, William ;
Levey, Andrew S. ;
Ornt, Daniel B. ;
Schulman, Gerald ;
Schwab, Steven ;
Teehan, Brendan ;
Eknoyan, Garabed .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (02) :546-555
[5]
Descamps-Latscha A, 2005, AM J KIDNEY DIS, V45, P39, DOI 10.1053/j.ajkd.2004.09.011
[6]
Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease [J].
Drüeke, T ;
Witko-Sarsat, V ;
Massy, Z ;
Descamps-Latscha, B ;
Guerin, AP ;
Marchais, SJ ;
Gausson, V ;
London, GM .
CIRCULATION, 2002, 106 (17) :2212-2217
[7]
Friedlander MA, 1996, CLIN NEPHROL, V45, P379
[8]
Endothelial function and oxidative stress in renovascular hypertension [J].
Higashi, Y ;
Sasaki, S ;
Nakagawa, K ;
Matsuura, H ;
Oshima, T ;
Chayama, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (25) :1954-1962
[9]
Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress" [J].
Jadoul, M ;
Ueda, Y ;
Yasuda, Y ;
Saito, A ;
Robert, A ;
Ishida, N ;
Kurokawa, K ;
de Strihou, CV ;
Miyata, T .
KIDNEY INTERNATIONAL, 1999, 55 (06) :2487-2492
[10]
Renal catabolism of advanced glycation end products: The fate of pentosidine [J].
Miyata, T ;
Ueda, Y ;
Horie, K ;
Nangaku, M ;
Tanaka, S ;
de Strihou, CV ;
Kurokawa, K .
KIDNEY INTERNATIONAL, 1998, 53 (02) :416-422